Kraig Biocraft Laboratories (KBLB) Stock Statistics & Valuation Metrics

Kraig Biocraft Laboratories has a market cap or net worth of $151.33M. The enterprise value is -$1.62T.

Kraig Biocraft Laboratories has 1,099,791,700 shares outstanding. The number of shares has decreased by -2.65% in one year.

Kraig Biocraft Laboratories’s return on equity (ROE) is 0.45 and return on invested capital (ROIC) is <0.01%.

The current PE Ratio of Kraig Biocraft Laboratories is ―. Kraig Biocraft Laboratories’s PEG ratio is -8.25.

In the last 12 months, Kraig Biocraft Laboratories had revenue of 0.00 and earned -3.62M in profits. Earnings per share was >-0.01.

In the last 12 months, operating cash flow was -1.79T and capital expenditures -5.39B, giving a free cash flow of -1.79T billion.

Kraig Biocraft Laboratories pays an annual dividend of ―, resulting in a dividend yield of ―

Kraig Biocraft Laboratories upcoming earnings date is ―, ―.

Kraig Biocraft Laboratories as a current ratio of 0.18, with Debt / Equity ratio of -2139803.71%

In the past 12 months, Kraig Biocraft Laboratories has paid 0.00 in taxes.

Kraig Biocraft Laboratories EV to EBITDA ratio is 534.75K, with an EV/FCF ratio of 0.90.

Kraig Biocraft Laboratories has $1.79T in cash and marketable securities with $171.16B in debt, giving a net cash position of $1.62T billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Kraig Biocraft Laboratories is ―, which is 11.43% higher than the current price. The consensus rating is ―